Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): Results from a phase III, prospective…

Overview of attention for article published in Journal of Clinical Oncology, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet
twitter: 10 X users

patent: 1 patent
guideline: 1 clinical guideline source

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 103,889 followers.

RT @DrChoueiri: 4/ Phase III CONDOR Study: PSMA-Targeted Imaging with 18F-DCFPyL-PET/CT biochem. recur. #PCa : PSMA-targeted PyL-PET/CT det…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.